Literature DB >> 15490028

Psychometric evaluation of the Taiwan version of the Disability of the Arm, Shoulder, and Hand (DASH) questionnaire.

Huey-Wen Liang1, Hsing-Kuo Wang, Grace Yao, Yi-Shiung Horng, Sheng-Mou Hou.   

Abstract

BACKGROUND AND
PURPOSE: To adapt the Taiwan version of the Disability of the Arm, Shoulder, and Hand (DASH) questionnaire and evaluate its psychometric properties.
METHODS: The DASH questionnaire was adapted through the process of translation, back-translation, and expert review. Eighty two subjects with upper extremity disorders were recruited in a medical center and 46 of these patients could be followed up to assess retest reliability in less than 10 days. Cronbach alpha and intraclass correlation coefficient were used to evaluate the internal consistency and test-retest reliability. Principal axis factor analysis was performed to assess the factor-construct validity, while concurrent validity was tested with the Medical Outcomes Study Short Form-36 (SF-36) Taiwan version questionnaire.
RESULTS: The internal consistency of the Taiwan version of the DASH questionnaire was high (Cronbach alpha = 0.96) and the test-retest reliability was satisfactory (intraclass correlation coefficient = 0.9). Principal axis factor analysis confirmed the 1-factor model. The Pearson correlation coefficients of the DASH questionnaire to the SF-36 showed a correlation with physical component summary scores rather than mental component summary scores. Bodily pain, physical function and role-physical scores among the SF-36 subscales were most significantly correlated with DASH disability/symptom scores.
CONCLUSION: The Taiwan version of the DASH questionnaire is a valid and reliable measure of health status for patients with upper-extremity disorders.

Entities:  

Mesh:

Year:  2004        PMID: 15490028

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  8 in total

1.  Can ICF model for patients with breast-cancer-related lymphedema predict quality of life?

Authors:  Jau-Yih Tsauo; Hsiu-Chuan Hung; Han-Ju Tsai; Chiun-Sheng Huang
Journal:  Support Care Cancer       Date:  2010-04-06       Impact factor: 3.603

2.  Physical therapy utilization in subjects with work-related musculoskeletal disorders: Taiwan experience.

Authors:  Jau-Yih Tsauo; Huey-Wen Liang; Yuh Jang; Chung-Li Du
Journal:  J Occup Rehabil       Date:  2008-12-24

3.  Validation of the Chinese version of the Boston Carpal Tunnel Questionnaire.

Authors:  Yi-Jing Lue; Yen-Mou Lu; Gau-Tyan Lin; Ya-Fen Liu
Journal:  J Occup Rehabil       Date:  2014-03

4.  Adaptation of Turkish version of the questionnaire Quick Disability of the Arm, Shoulder, and Hand (Quick DASH) in patients with carpal tunnel syndrome.

Authors:  Sebnem Koldas Dogan; Saime Ay; Deniz Evcik; Ozgun Baser
Journal:  Clin Rheumatol       Date:  2010-04-22       Impact factor: 2.980

5.  A randomized controlled trial of scapular exercises with electromyography biofeedback in oral cancer patients with accessory nerve dysfunction.

Authors:  Yueh-Hsia Chen; Wei-An Liang; Chi-Rung Lin; Cheng-Ya Huang
Journal:  Support Care Cancer       Date:  2022-07-11       Impact factor: 3.359

6.  Validation of the simplified Chinese (Mainland) version of the Disability of the Arm, Shoulder, and Hand questionnaire (DASH-CHNPLAGH).

Authors:  Hua Chen; Xinran Ji; Wei Zhang; Yiling Zhang; Lihai Zhang; Peifu Tang
Journal:  J Orthop Surg Res       Date:  2015-05-23       Impact factor: 2.359

7.  Systematic review of the quality of the cross-cultural adaptations of Disabilities of the Arm, Shoulder and Hand (DASH).

Authors:  Ilkem Ceren Sigirtmac; Cigdem Oksuz
Journal:  Med Lav       Date:  2021-08-26       Impact factor: 1.275

8.  Structural validity of the Dutch version of the disability of arm, shoulder and hand questionnaire (DASH-DLV) in adult patients with hand and wrist injuries.

Authors:  M E van Eck; C M Lameijer; M El Moumni
Journal:  BMC Musculoskelet Disord       Date:  2018-06-30       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.